Human Insulin Delivery System market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Human Insulin Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Automatic Manual Segment by Application Hospitals Clinics Homecare By Company BD Novo Nordisk Medtronic Sanofi ELI Lilly and Company Ypsomed Holding Animas Corporation Tandem Diabetes Care Insulet Corporation Biocon Roche Johnson & Johnson Microport By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
1 Study Coverage 1.1 Human Insulin Delivery System Product Introduction 1.2 Market by Type 1.2.1 Global Human Insulin Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Automatic 1.2.3 Manual 1.3 Market by Application 1.3.1 Global Human Insulin Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Homecare 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Human Insulin Delivery System Sales Estimates and Forecasts 2017-2028 2.2 Global Human Insulin Delivery System Revenue Estimates and Forecasts 2017-2028 2.3 Global Human Insulin Delivery System Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Human Insulin Delivery System Sales by Region 2.4.1 Global Human Insulin Delivery System Sales by Region (2017-2022) 2.4.2 Global Sales Human Insulin Delivery System by Region (2023-2028) 2.5 Global Human Insulin Delivery System Revenue by Region 2.5.1 Global Human Insulin Delivery System Revenue by Region (2017-2022) 2.5.2 Global Human Insulin Delivery System Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Human Insulin Delivery System Sales by Manufacturers 3.1.1 Global Top Human Insulin Delivery System Manufacturers by Sales (2017-2022) 3.1.2 Global Human Insulin Delivery System Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Insulin Delivery System in 2021 3.2 Global Human Insulin Delivery System Revenue by Manufacturers 3.2.1 Global Human Insulin Delivery System Revenue by Manufacturers (2017-2022) 3.2.2 Global Human Insulin Delivery System Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Human Insulin Delivery System Revenue in 2021 3.3 Global Human Insulin Delivery System Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Human Insulin Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Human Insulin Delivery System Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Human Insulin Delivery System Sales by Type 4.1.1 Global Human Insulin Delivery System Historical Sales by Type (2017-2022) 4.1.2 Global Human Insulin Delivery System Forecasted Sales by Type (2023-2028) 4.1.3 Global Human Insulin Delivery System Sales Market Share by Type (2017-2028) 4.2 Global Human Insulin Delivery System Revenue by Type 4.2.1 Global Human Insulin Delivery System Historical Revenue by Type (2017-2022) 4.2.2 Global Human Insulin Delivery System Forecasted Revenue by Type (2023-2028) 4.2.3 Global Human Insulin Delivery System Revenue Market Share by Type (2017-2028) 4.3 Global Human Insulin Delivery System Price by Type 4.3.1 Global Human Insulin Delivery System Price by Type (2017-2022) 4.3.2 Global Human Insulin Delivery System Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Human Insulin Delivery System Sales by Application 5.1.1 Global Human Insulin Delivery System Historical Sales by Application (2017-2022) 5.1.2 Global Human Insulin Delivery System Forecasted Sales by Application (2023-2028) 5.1.3 Global Human Insulin Delivery System Sales Market Share by Application (2017-2028) 5.2 Global Human Insulin Delivery System Revenue by Application 5.2.1 Global Human Insulin Delivery System Historical Revenue by Application (2017-2022) 5.2.2 Global Human Insulin Delivery System Forecasted Revenue by Application (2023-2028) 5.2.3 Global Human Insulin Delivery System Revenue Market Share by Application (2017-2028) 5.3 Global Human Insulin Delivery System Price by Application 5.3.1 Global Human Insulin Delivery System Price by Application (2017-2022) 5.3.2 Global Human Insulin Delivery System Price Forecast by Application (2023-2028) 6 North America 6.1 North America Human Insulin Delivery System Market Size by Type 6.1.1 North America Human Insulin Delivery System Sales by Type (2017-2028) 6.1.2 North America Human Insulin Delivery System Revenue by Type (2017-2028) 6.2 North America Human Insulin Delivery System Market Size by Application 6.2.1 North America Human Insulin Delivery System Sales by Application (2017-2028) 6.2.2 North America Human Insulin Delivery System Revenue by Application (2017-2028) 6.3 North America Human Insulin Delivery System Market Size by Country 6.3.1 North America Human Insulin Delivery System Sales by Country (2017-2028) 6.3.2 North America Human Insulin Delivery System Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Human Insulin Delivery System Market Size by Type 7.1.1 Europe Human Insulin Delivery System Sales by Type (2017-2028) 7.1.2 Europe Human Insulin Delivery System Revenue by Type (2017-2028) 7.2 Europe Human Insulin Delivery System Market Size by Application 7.2.1 Europe Human Insulin Delivery System Sales by Application (2017-2028) 7.2.2 Europe Human Insulin Delivery System Revenue by Application (2017-2028) 7.3 Europe Human Insulin Delivery System Market Size by Country 7.3.1 Europe Human Insulin Delivery System Sales by Country (2017-2028) 7.3.2 Europe Human Insulin Delivery System Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Human Insulin Delivery System Market Size by Type 8.1.1 Asia Pacific Human Insulin Delivery System Sales by Type (2017-2028) 8.1.2 Asia Pacific Human Insulin Delivery System Revenue by Type (2017-2028) 8.2 Asia Pacific Human Insulin Delivery System Market Size by Application 8.2.1 Asia Pacific Human Insulin Delivery System Sales by Application (2017-2028) 8.2.2 Asia Pacific Human Insulin Delivery System Revenue by Application (2017-2028) 8.3 Asia Pacific Human Insulin Delivery System Market Size by Region 8.3.1 Asia Pacific Human Insulin Delivery System Sales by Region (2017-2028) 8.3.2 Asia Pacific Human Insulin Delivery System Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Human Insulin Delivery System Market Size by Type 9.1.1 Latin America Human Insulin Delivery System Sales by Type (2017-2028) 9.1.2 Latin America Human Insulin Delivery System Revenue by Type (2017-2028) 9.2 Latin America Human Insulin Delivery System Market Size by Application 9.2.1 Latin America Human Insulin Delivery System Sales by Application (2017-2028) 9.2.2 Latin America Human Insulin Delivery System Revenue by Application (2017-2028) 9.3 Latin America Human Insulin Delivery System Market Size by Country 9.3.1 Latin America Human Insulin Delivery System Sales by Country (2017-2028) 9.3.2 Latin America Human Insulin Delivery System Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Human Insulin Delivery System Market Size by Type 10.1.1 Middle East and Africa Human Insulin Delivery System Sales by Type (2017-2028) 10.1.2 Middle East and Africa Human Insulin Delivery System Revenue by Type (2017-2028) 10.2 Middle East and Africa Human Insulin Delivery System Market Size by Application 10.2.1 Middle East and Africa Human Insulin Delivery System Sales by Application (2017-2028) 10.2.2 Middle East and Africa Human Insulin Delivery System Revenue by Application (2017-2028) 10.3 Middle East and Africa Human Insulin Delivery System Market Size by Country 10.3.1 Middle East and Africa Human Insulin Delivery System Sales by Country (2017-2028) 10.3.2 Middle East and Africa Human Insulin Delivery System Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 BD 11.1.1 BD Corporation Information 11.1.2 BD Overview 11.1.3 BD Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 BD Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 BD Recent Developments 11.2 Novo Nordisk 11.2.1 Novo Nordisk Corporation Information 11.2.2 Novo Nordisk Overview 11.2.3 Novo Nordisk Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Novo Nordisk Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Novo Nordisk Recent Developments 11.3 Medtronic 11.3.1 Medtronic Corporation Information 11.3.2 Medtronic Overview 11.3.3 Medtronic Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Medtronic Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Medtronic Recent Developments 11.4 Sanofi 11.4.1 Sanofi Corporation Information 11.4.2 Sanofi Overview 11.4.3 Sanofi Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Sanofi Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Sanofi Recent Developments 11.5 ELI Lilly and Company 11.5.1 ELI Lilly and Company Corporation Information 11.5.2 ELI Lilly and Company Overview 11.5.3 ELI Lilly and Company Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 ELI Lilly and Company Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 ELI Lilly and Company Recent Developments 11.6 Ypsomed Holding 11.6.1 Ypsomed Holding Corporation Information 11.6.2 Ypsomed Holding Overview 11.6.3 Ypsomed Holding Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Ypsomed Holding Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Ypsomed Holding Recent Developments 11.7 Animas Corporation 11.7.1 Animas Corporation Corporation Information 11.7.2 Animas Corporation Overview 11.7.3 Animas Corporation Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Animas Corporation Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Animas Corporation Recent Developments 11.8 Tandem Diabetes Care 11.8.1 Tandem Diabetes Care Corporation Information 11.8.2 Tandem Diabetes Care Overview 11.8.3 Tandem Diabetes Care Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Tandem Diabetes Care Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Tandem Diabetes Care Recent Developments 11.9 Insulet Corporation 11.9.1 Insulet Corporation Corporation Information 11.9.2 Insulet Corporation Overview 11.9.3 Insulet Corporation Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Insulet Corporation Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Insulet Corporation Recent Developments 11.10 Biocon 11.10.1 Biocon Corporation Information 11.10.2 Biocon Overview 11.10.3 Biocon Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Biocon Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Biocon Recent Developments 11.11 Roche 11.11.1 Roche Corporation Information 11.11.2 Roche Overview 11.11.3 Roche Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Roche Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Roche Recent Developments 11.12 Johnson & Johnson 11.12.1 Johnson & Johnson Corporation Information 11.12.2 Johnson & Johnson Overview 11.12.3 Johnson & Johnson Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Johnson & Johnson Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Johnson & Johnson Recent Developments 11.13 Microport 11.13.1 Microport Corporation Information 11.13.2 Microport Overview 11.13.3 Microport Human Insulin Delivery System Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 Microport Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Microport Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Human Insulin Delivery System Industry Chain Analysis 12.2 Human Insulin Delivery System Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Human Insulin Delivery System Production Mode & Process 12.4 Human Insulin Delivery System Sales and Marketing 12.4.1 Human Insulin Delivery System Sales Channels 12.4.2 Human Insulin Delivery System Distributors 12.5 Human Insulin Delivery System Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Human Insulin Delivery System Industry Trends 13.2 Human Insulin Delivery System Market Drivers 13.3 Human Insulin Delivery System Market Challenges 13.4 Human Insulin Delivery System Market Restraints 14 Key Findings in The Global Human Insulin Delivery System Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
List of Tables Table 1. Global Human Insulin Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Automatic Table 3. Major Manufacturers of Manual Table 4. Global Human Insulin Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global Human Insulin Delivery System Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Human Insulin Delivery System Sales by Region (2017-2022) & (K Units) Table 7. Global Human Insulin Delivery System Sales Market Share by Region (2017-2022) Table 8. Global Human Insulin Delivery System Sales by Region (2023-2028) & (K Units) Table 9. Global Human Insulin Delivery System Sales Market Share by Region (2023-2028) Table 10. Global Human Insulin Delivery System Revenue by Region (2017-2022) & (US$ Million) Table 11. Global Human Insulin Delivery System Revenue Market Share by Region (2017-2022) Table 12. Global Human Insulin Delivery System Revenue by Region (2023-2028) & (US$ Million) Table 13. Global Human Insulin Delivery System Revenue Market Share by Region (2023-2028) Table 14. Global Human Insulin Delivery System Sales by Manufacturers (2017-2022) & (K Units) Table 15. Global Human Insulin Delivery System Sales Share by Manufacturers (2017-2022) Table 16. Global Human Insulin Delivery System Revenue by Manufacturers (2017-2022) & (US$ Million) Table 17. Global Human Insulin Delivery System Revenue Share by Manufacturers (2017-2022) Table 18. Human Insulin Delivery System Price by Manufacturers (2017-2022) &(US$/Unit) Table 19. Global Human Insulin Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Human Insulin Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin Delivery System as of 2021) Table 21. Human Insulin Delivery System Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Human Insulin Delivery System Product Offered Table 23. Date of Manufacturers Enter into Human Insulin Delivery System Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Human Insulin Delivery System Sales by Type (2017-2022) & (K Units) Table 26. Global Human Insulin Delivery System Sales by Type (2023-2028) & (K Units) Table 27. Global Human Insulin Delivery System Sales Share by Type (2017-2022) Table 28. Global Human Insulin Delivery System Sales Share by Type (2023-2028) Table 29. Global Human Insulin Delivery System Revenue by Type (2017-2022) & (US$ Million) Table 30. Global Human Insulin Delivery System Revenue by Type (2023-2028) & (US$ Million) Table 31. Global Human Insulin Delivery System Revenue Share by Type (2017-2022) Table 32. Global Human Insulin Delivery System Revenue Share by Type (2023-2028) Table 33. Human Insulin Delivery System Price by Type (2017-2022) & (US$/Unit) Table 34. Global Human Insulin Delivery System Price Forecast by Type (2023-2028) & (US$/Unit) Table 35. Global Human Insulin Delivery System Sales by Application (2017-2022) & (K Units) Table 36. Global Human Insulin Delivery System Sales by Application (2023-2028) & (K Units) Table 37. Global Human Insulin Delivery System Sales Share by Application (2017-2022) Table 38. Global Human Insulin Delivery System Sales Share by Application (2023-2028) Table 39. Global Human Insulin Delivery System Revenue by Application (2017-2022) & (US$ Million) Table 40. Global Human Insulin Delivery System Revenue by Application (2023-2028) & (US$ Million) Table 41. Global Human Insulin Delivery System Revenue Share by Application (2017-2022) Table 42. Global Human Insulin Delivery System Revenue Share by Application (2023-2028) Table 43. Human Insulin Delivery System Price by Application (2017-2022) & (US$/Unit) Table 44. Global Human Insulin Delivery System Price Forecast by Application (2023-2028) & (US$/Unit) Table 45. North America Human Insulin Delivery System Sales by Type (2017-2022) & (K Units) Table 46. North America Human Insulin Delivery System Sales by Type (2023-2028) & (K Units) Table 47. North America Human Insulin Delivery System Revenue by Type (2017-2022) & (US$ Million) Table 48. North America Human Insulin Delivery System Revenue by Type (2023-2028) & (US$ Million) Table 49. North America Human Insulin Delivery System Sales by Application (2017-2022) & (K Units) Table 50. North America Human Insulin Delivery System Sales by Application (2023-2028) & (K Units) Table 51. North America Human Insulin Delivery System Revenue by Application (2017-2022) & (US$ Million) Table 52. North America Human Insulin Delivery System Revenue by Application (2023-2028) & (US$ Million) Table 53. North America Human Insulin Delivery System Sales by Country (2017-2022) & (K Units) Table 54. North America Human Insulin Delivery System Sales by Country (2023-2028) & (K Units) Table 55. North America Human Insulin Delivery System Revenue by Country (2017-2022) & (US$ Million) Table 56. North America Human Insulin Delivery System Revenue by Country (2023-2028) & (US$ Million) Table 57. Europe Human Insulin Delivery System Sales by Type (2017-2022) & (K Units) Table 58. Europe Human Insulin Delivery System Sales by Type (2023-2028) & (K Units) Table 59. Europe Human Insulin Delivery System Revenue by Type (2017-2022) & (US$ Million) Table 60. Europe Human Insulin Delivery System Revenue by Type (2023-2028) & (US$ Million) Table 61. Europe Human Insulin Delivery System Sales by Application (2017-2022) & (K Units) Table 62. Europe Human Insulin Delivery System Sales by Application (2023-2028) & (K Units) Table 63. Europe Human Insulin Delivery System Revenue by Application (2017-2022) & (US$ Million) Table 64. Europe Human Insulin Delivery System Revenue by Application (2023-2028) & (US$ Million) Table 65. Europe Human Insulin Delivery System Sales by Country (2017-2022) & (K Units) Table 66. Europe Human Insulin Delivery System Sales by Country (2023-2028) & (K Units) Table 67. Europe Human Insulin Delivery System Revenue by Country (2017-2022) & (US$ Million) Table 68. Europe Human Insulin Delivery System Revenue by Country (2023-2028) & (US$ Million) Table 69. Asia Pacific Human Insulin Delivery System Sales by Type (2017-2022) & (K Units) Table 70. Asia Pacific Human Insulin Delivery System Sales by Type (2023-2028) & (K Units) Table 71. Asia Pacific Human Insulin Delivery System Revenue by Type (2017-2022) & (US$ Million) Table 72. Asia Pacific Human Insulin Delivery System Revenue by Type (2023-2028) & (US$ Million) Table 73. Asia Pacific Human Insulin Delivery System Sales by Application (2017-2022) & (K Units) Table 74. Asia Pacific Human Insulin Delivery System Sales by Application (2023-2028) & (K Units) Table 75. Asia Pacific Human Insulin Delivery System Revenue by Application (2017-2022) & (US$ Million) Table 76. Asia Pacific Human Insulin Delivery System Revenue by Application (2023-2028) & (US$ Million) Table 77. Asia Pacific Human Insulin Delivery System Sales by Region (2017-2022) & (K Units) Table 78. Asia Pacific Human Insulin Delivery System Sales by Region (2023-2028) & (K Units) Table 79. Asia Pacific Human Insulin Delivery System Revenue by Region (2017-2022) & (US$ Million) Table 80. Asia Pacific Human Insulin Delivery System Revenue by Region (2023-2028) & (US$ Million) Table 81. Latin America Human Insulin Delivery System Sales by Type (2017-2022) & (K Units) Table 82. Latin America Human Insulin Delivery System Sales by Type (2023-2028) & (K Units) Table 83. Latin America Human Insulin Delivery System Revenue by Type (2017-2022) & (US$ Million) Table 84. Latin America Human Insulin Delivery System Revenue by Type (2023-2028) & (US$ Million) Table 85. Latin America Human Insulin Delivery System Sales by Application (2017-2022) & (K Units) Table 86. Latin America Human Insulin Delivery System Sales by Application (2023-2028) & (K Units) Table 87. Latin America Human Insulin Delivery System Revenue by Application (2017-2022) & (US$ Million) Table 88. Latin America Human Insulin Delivery System Revenue by Application (2023-2028) & (US$ Million) Table 89. Latin America Human Insulin Delivery System Sales by Country (2017-2022) & (K Units) Table 90. Latin America Human Insulin Delivery System Sales by Country (2023-2028) & (K Units) Table 91. Latin America Human Insulin Delivery System Revenue by Country (2017-2022) & (US$ Million) Table 92. Latin America Human Insulin Delivery System Revenue by Country (2023-2028) & (US$ Million) Table 93. Middle East and Africa Human Insulin Delivery System Sales by Type (2017-2022) & (K Units) Table 94. Middle East and Africa Human Insulin Delivery System Sales by Type (2023-2028) & (K Units) Table 95. Middle East and Africa Human Insulin Delivery System Revenue by Type (2017-2022) & (US$ Million) Table 96. Middle East and Africa Human Insulin Delivery System Revenue by Type (2023-2028) & (US$ Million) Table 97. Middle East and Africa Human Insulin Delivery System Sales by Application (2017-2022) & (K Units) Table 98. Middle East and Africa Human Insulin Delivery System Sales by Application (2023-2028) & (K Units) Table 99. Middle East and Africa Human Insulin Delivery System Revenue by Application (2017-2022) & (US$ Million) Table 100. Middle East and Africa Human Insulin Delivery System Revenue by Application (2023-2028) & (US$ Million) Table 101. Middle East and Africa Human Insulin Delivery System Sales by Country (2017-2022) & (K Units) Table 102. Middle East and Africa Human Insulin Delivery System Sales by Country (2023-2028) & (K Units) Table 103. Middle East and Africa Human Insulin Delivery System Revenue by Country (2017-2022) & (US$ Million) Table 104. Middle East and Africa Human Insulin Delivery System Revenue by Country (2023-2028) & (US$ Million) Table 105. BD Corporation Information Table 106. BD Description and Major Businesses Table 107. BD Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 108. BD Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 109. BD Recent Developments Table 110. Novo Nordisk Corporation Information Table 111. Novo Nordisk Description and Major Businesses Table 112. Novo Nordisk Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 113. Novo Nordisk Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 114. Novo Nordisk Recent Developments Table 115. Medtronic Corporation Information Table 116. Medtronic Description and Major Businesses Table 117. Medtronic Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 118. Medtronic Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 119. Medtronic Recent Developments Table 120. Sanofi Corporation Information Table 121. Sanofi Description and Major Businesses Table 122. Sanofi Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 123. Sanofi Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 124. Sanofi Recent Developments Table 125. ELI Lilly and Company Corporation Information Table 126. ELI Lilly and Company Description and Major Businesses Table 127. ELI Lilly and Company Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 128. ELI Lilly and Company Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 129. ELI Lilly and Company Recent Developments Table 130. Ypsomed Holding Corporation Information Table 131. Ypsomed Holding Description and Major Businesses Table 132. Ypsomed Holding Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 133. Ypsomed Holding Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 134. Ypsomed Holding Recent Developments Table 135. Animas Corporation Corporation Information Table 136. Animas Corporation Description and Major Businesses Table 137. Animas Corporation Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 138. Animas Corporation Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 139. Animas Corporation Recent Developments Table 140. Tandem Diabetes Care Corporation Information Table 141. Tandem Diabetes Care Description and Major Businesses Table 142. Tandem Diabetes Care Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 143. Tandem Diabetes Care Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 144. Tandem Diabetes Care Recent Developments Table 145. Insulet Corporation Corporation Information Table 146. Insulet Corporation Description and Major Businesses Table 147. Insulet Corporation Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 148. Insulet Corporation Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 149. Insulet Corporation Recent Developments Table 150. Biocon Corporation Information Table 151. Biocon Description and Major Businesses Table 152. Biocon Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 153. Biocon Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 154. Biocon Recent Developments Table 155. Roche Corporation Information Table 156. Roche Description and Major Businesses Table 157. Roche Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 158. Roche Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 159. Roche Recent Developments Table 160. Johnson & Johnson Corporation Information Table 161. Johnson & Johnson Description and Major Businesses Table 162. Johnson & Johnson Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 163. Johnson & Johnson Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 164. Johnson & Johnson Recent Developments Table 165. Microport Corporation Information Table 166. Microport Description and Major Businesses Table 167. Microport Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 168. Microport Human Insulin Delivery System Product Model Numbers, Pictures, Descriptions and Specifications Table 169. Microport Recent Developments Table 170. Key Raw Materials Lists Table 171. Raw Materials Key Suppliers Lists Table 172. Human Insulin Delivery System Distributors List Table 173. Human Insulin Delivery System Customers List Table 174. Human Insulin Delivery System Market Trends Table 175. Human Insulin Delivery System Market Drivers Table 176. Human Insulin Delivery System Market Challenges Table 177. Human Insulin Delivery System Market Restraints Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Human Insulin Delivery System Product Picture Figure 3. Global Human Insulin Delivery System Market Share by Type in 2021 & 2028 Figure 3. Automatic Product Picture Figure 4. Manual Product Picture Figure 5. Global Human Insulin Delivery System Market Share by Application in 2021 & 2028 Figure 6. Hospitals Figure 7. Clinics Figure 8. Homecare Figure 9. Human Insulin Delivery System Report Years Considered Figure 10. Global Human Insulin Delivery System Sales 2017-2028 (K Units) Figure 11. Global Human Insulin Delivery System Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Human Insulin Delivery System Revenue 2017-2028 (US$ Million) Figure 13. Global Human Insulin Delivery System Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 14. Global Human Insulin Delivery System Sales Market Share by Region (2017-2022) Figure 15. Global Human Insulin Delivery System Sales Market Share by Region (2023-2028) Figure 16. North America Human Insulin Delivery System Sales YoY (2017-2028) & (K Units) Figure 17. North America Human Insulin Delivery System Revenue YoY (2017-2028) & (US$ Million) Figure 18. Europe Human Insulin Delivery System Sales YoY (2017-2028) & (K Units) Figure 19. Europe Human Insulin Delivery System Revenue YoY (2017-2028) & (US$ Million) Figure 20. Asia-Pacific Human Insulin Delivery System Sales YoY (2017-2028) & (K Units) Figure 21. Asia-Pacific Human Insulin Delivery System Revenue YoY (2017-2028) & (US$ Million) Figure 22. Latin America Human Insulin Delivery System Sales YoY (2017-2028) & (K Units) Figure 23. Latin America Human Insulin Delivery System Revenue YoY (2017-2028) & (US$ Million) Figure 24. Middle East & Africa Human Insulin Delivery System Sales YoY (2017-2028) & (K Units) Figure 25. Middle East & Africa Human Insulin Delivery System Revenue YoY (2017-2028) & (US$ Million) Figure 26. The Human Insulin Delivery System Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 27. The Top 5 and 10 Largest Manufacturers of Human Insulin Delivery System in the World: Market Share by Human Insulin Delivery System Revenue in 2021 Figure 28. Global Human Insulin Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 29. Global Human Insulin Delivery System Sales Market Share by Type (2017-2028) Figure 30. Global Human Insulin Delivery System Revenue Market Share by Type (2017-2028) Figure 31. Global Human Insulin Delivery System Sales Market Share by Application (2017-2028) Figure 32. Global Human Insulin Delivery System Revenue Market Share by Application (2017-2028) Figure 33. North America Human Insulin Delivery System Sales Market Share by Type (2017-2028) Figure 34. North America Human Insulin Delivery System Revenue Market Share by Type (2017-2028) Figure 35. North America Human Insulin Delivery System Sales Market Share by Application (2017-2028) Figure 36. North America Human Insulin Delivery System Revenue Market Share by Application (2017-2028) Figure 37. North America Human Insulin Delivery System Sales Share by Country (2017-2028) Figure 38. North America Human Insulin Delivery System Revenue Share by Country (2017-2028) Figure 39. U.S. Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 40. Canada Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 41. Europe Human Insulin Delivery System Sales Market Share by Type (2017-2028) Figure 42. Europe Human Insulin Delivery System Revenue Market Share by Type (2017-2028) Figure 43. Europe Human Insulin Delivery System Sales Market Share by Application (2017-2028) Figure 44. Europe Human Insulin Delivery System Revenue Market Share by Application (2017-2028) Figure 45. Europe Human Insulin Delivery System Sales Share by Country (2017-2028) Figure 46. Europe Human Insulin Delivery System Revenue Share by Country (2017-2028) Figure 47. Germany Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 48. France Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 49. U.K. Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 50. Italy Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 51. Russia Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 52. Asia Pacific Human Insulin Delivery System Sales Market Share by Type (2017-2028) Figure 53. Asia Pacific Human Insulin Delivery System Revenue Market Share by Type (2017-2028) Figure 54. Asia Pacific Human Insulin Delivery System Sales Market Share by Application (2017-2028) Figure 55. Asia Pacific Human Insulin Delivery System Revenue Market Share by Application (2017-2028) Figure 56. Asia Pacific Human Insulin Delivery System Sales Share by Region (2017-2028) Figure 57. Asia Pacific Human Insulin Delivery System Revenue Share by Region (2017-2028) Figure 58. China Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 59. Japan Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 60. South Korea Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 61. India Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 62. Australia Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 63. Taiwan Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 64. Indonesia Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 65. Thailand Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 66. Malaysia Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 67. Philippines Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 68. Latin America Human Insulin Delivery System Sales Market Share by Type (2017-2028) Figure 69. Latin America Human Insulin Delivery System Revenue Market Share by Type (2017-2028) Figure 70. Latin America Human Insulin Delivery System Sales Market Share by Application (2017-2028) Figure 71. Latin America Human Insulin Delivery System Revenue Market Share by Application (2017-2028) Figure 72. Latin America Human Insulin Delivery System Sales Share by Country (2017-2028) Figure 73. Latin America Human Insulin Delivery System Revenue Share by Country (2017-2028) Figure 74. Mexico Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 75. Brazil Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 76. Argentina Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 77. Middle East and Africa Human Insulin Delivery System Sales Market Share by Type (2017-2028) Figure 78. Middle East and Africa Human Insulin Delivery System Revenue Market Share by Type (2017-2028) Figure 79. Middle East and Africa Human Insulin Delivery System Sales Market Share by Application (2017-2028) Figure 80. Middle East and Africa Human Insulin Delivery System Revenue Market Share by Application (2017-2028) Figure 81. Middle East and Africa Human Insulin Delivery System Sales Share by Country (2017-2028) Figure 82. Middle East and Africa Human Insulin Delivery System Revenue Share by Country (2017-2028) Figure 83. Turkey Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 84. Saudi Arabia Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 85. UAE Human Insulin Delivery System Revenue (2017-2028) & (US$ Million) Figure 86. Human Insulin Delivery System Value Chain Figure 87. Human Insulin Delivery System Production Process Figure 88. Channels of Distribution Figure 89. Distributors Profiles Figure 90. Bottom-up and Top-down Approaches for This Report Figure 91. Data Triangulation Figure 92. Key Executives Interviewed